In this roundtable discussion, immuno-oncology decision-making experts from pharma, biotech, and academia discuss the complexity of cancer and its diagnosis.The panel also share their perspectives on current and future approaches towards cancer management and explore paradigm shifts surrounding immuno- and precision oncology.